Biggest News Aggregation in the World
📰 Cancer Program News

Page 15 - Cancer Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cancer Program. Real-time updates on events, politics, business and more.

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

Drs Simeone and Fakih discuss the main objective and design of the observational BASECAMP-1 study and how it functions alongside the EVEREST-1 study, which is evaluating the autologous CAR T-cell therapy A2B530 in patients with CEA-expressing solid tumors that have lost HLA-A*02 expression.
United States New York Marwang Fakih Judy Bernard Briskin Dianem Simeone Kyle Doherty

Dr Brufsky on the FDA Approval of Capivasertib Plus Fulvestrant in PIK3CA/AKT1/PTEN-Altered HR+/HER2– Breast Cancer

Adam M. Brufsky, MD, PhD, FACP, discusses the significance of the FDA approval of capivasertib in combination with fulvestrant for patients with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer harboring 1 or more PIK3CA, AKT1, or PTEN alterations.
Adamm Brufsky Department Of Medicine University Of Pittsburgh School Medicine Breast Cancer Center Division Of Hematology Oncology Hillman Cancer Center

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science